Trius Therapeutics (TSRX)

Add to Watchlists Create an Alert
7.88 -0.02  -0.25%   NASDAQ May 24, 10:36AM BATS Real time Currency in USD

Trius Therapeutics Revenue Quarterly:

1.727M for Dec. 31, 2012
View Full Chart

Trius Therapeutics Revenue Quarterly Chart

    Trius Therapeutics Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.727M
    Dec. 31, 2012 5.156M
    Sept. 30, 2012 5.973M
    June 30, 2012 6.224M
    March 31, 2012 9.832M
    Dec. 31, 2011 5.002M
    Sept. 30, 2011 30.44M
    June 30, 2011 2.859M
    March 31, 2011 2.715M
       
    Dec. 31, 2010 2.521M
    Sept. 30, 2010 1.94M
    June 30, 2010 2.084M
    March 31, 2010 1.486M
    Dec. 31, 2009 1.032M
    Sept. 30, 2009 1.691M
    June 30, 2009 1.209M
    March 31, 2009 1.085M
    Dec. 31, 2008 0.65M

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    TSRX Revenue Quarterly Benchmarks

    Companies
    Genomic Health 63.09M
    Acorda Therapeutics 71.86M
    Chembio Diagnostics 7.866M

    TSRX Revenue Quarterly Rankings

    Overall 42nd percentile
    4604 of 8009
    Sector 39th percentile
    416 of 687 in Healthcare
    Industry 33rd percentile
    43 of 65 in Diagnostics & Research

    TSRX Revenue Quarterly Range, Past 5 Years

    Minimum 0.6500M Dec 2008
    Maximum 30.44M Sep 2011
    Average 4.646M